MLchartDataset catalogue

copper Cu 67 SAR-bisPSMA

Term · Oncology and biomedicine · MLC-T-ONC-012766

A radioconjugate composed of two human prostate-specific membrane antigen (PSMA)-binding motifs linked to a sarcophagine (SAR)-based chelator and radiolabeled with the beta-emitting radioisotope copper Cu 67, with potential antineoplastic activity. Upon administration of copper Cu 67 SAR-bisPSMA, the PSMA-binding motifs target and bind to PSMA-expressing tumor cells, thereby delivering a cytotoxic dose of beta radiation to PSMA-expressing tumor cells. PSMA, a tumor-associated antigen (TAA) and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells as well as a variety of other solid tumors.

Table 1. Record
IdentifierMLC-T-ONC-012766
FieldOncology and biomedicine
Synonyms67Cu SAR-bisPSMA; 67Cu-SAR-bisPSMA; copper Cu 67-SAR-bisPSMA
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012766",
  "term": "copper Cu 67 SAR-bisPSMA",
  "field": "Oncology and biomedicine",
  "definition": "A radioconjugate composed of two human prostate-specific membrane antigen (PSMA)-binding motifs linked to a sarcophagine (SAR)-based chelator and radiolabeled with the beta-emitting radioisotope copper Cu 67, with potential antineoplastic activity. Upon administration of copper Cu 67 SAR-bisPSMA, the PSMA-binding motifs target and bind to PSMA-expressing tumor cells, thereby delivering a cytotoxic dose of beta radiation to PSMA-expressing tumor cells. PSMA, a tumor-associated antigen (TAA) and type II transmembrane protein, is expressed on the membrane of prostatic epithelial cells and overexpressed on prostate tumor cells as well as a variety of other solid tumors.",
  "synonyms": [
    "67Cu SAR-bisPSMA",
    "67Cu-SAR-bisPSMA",
    "copper Cu 67-SAR-bisPSMA"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/copper-cu-67-sar-bispsma/"
}

Record 5,317 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.